Results

Total Results: 2,080 records

Showing results for "drug".

221. PATIENTSLIKEME (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/clifford.pdf
     January 06, 2017 - So you can look and you can say, OK, what drug are they taking. They're taking Gabapentin. … amount of additional information about the utilization of that drug in the real world. … So it limits misattribution of things like nausea if someone's taking a drug and saying, OK, you know … What's the likelihood that my nausea today is being caused by this drug? … We had 10 times as many people on drug and 30 times as many controls in our trial, in observational

222. The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_executive.pdf
     September 19, 2014 - *Including opioid management plans, patient education, urine drug screening, use of prescription drug … The DAWN Report: Highlights of the 2010 Drug Abuse Warning Network (DAWN) Findings on Drug-Related … Food and Drug Administration. … Food and Drug Administration. … Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?

223. What do we know about how evidence of harm and benefit is communicated in other countries? (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_international_king.ppt
     January 01, 2005 - Does product discuss harm and benefit of treatment with the drug? … Guidelines for Diagnosis and Management of Osteoporosis in Canada (2002) Osteoporosis Canada Website, “Drug … increased risk of cardiovascular disease, their families and the public Canada Osteoporosis Canada “Drug … www.osteoporosis.ca Osteoporosis Canada: About Osteoporosis--Drug Treatments Appropriate … comparison of alternatives Yes, both discussed, but not in detail Yes, Explore with doctor and find best drug

224. 8 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
     November 01, 2008 - Adverse drug reactions: definitions, diagnosis, and management. … Center for Drug Evaluation and Research. … Adverse drug reactions: keeping up to date. … The Research on Adverse Drug Events and Reports (RADAR) project. … Adverse reaction/adverse drug reaction An adverse effect specifically associated with a drug.

225. 8 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
     November 01, 2008 - Adverse drug reactions: definitions, diagnosis, and management. … Center for Drug Evaluation and Research. … Adverse drug reactions: keeping up to date. … The Research on Adverse Drug Events and Reports (RADAR) project. … Adverse reaction/adverse drug reaction An adverse effect specifically associated with a drug.

226. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression_hi_impact.pdf
     October 01, 2014 - Food and Drug Administration (FDA) approval of any DBS device for a psychiatric indication. … DBS is indicated to complement conventional drug therapy for MDD or OCD. … dosages or different drug regimens. … The drug different effect size was largest at day 2. … Food and Drug Administration (FDA); 2010 Apr 1 [accessed 2011 May 23]. [19 p].

227. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - A drug for psychotic major depression (PMD), for which the U.S. … administration and is known to be a street drug of abuse. … Research suggests new drug targets for depression. … Food and Drug Administration (FDA) [accessed 2012 Mar 15]. [2 p]. … Washington (DC): Drug Enforcement Administration, U.S.

228. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - drug- name=qsymia. … drug-name=xenical http://www.goodrx.com/xenical?drug-name=xenical http://www.goodrx.com/belviq? … drug-name=belviq http://www.goodrx.com/belviq?drug-name=belviq http://www.goodrx.com/contrave? … drug-name=contrave http://www.goodrx.com/contrave?drug-name=contrave http://www.goodrx.com/qsymia? … drug-name=qsymia http://www.goodrx.com/qsymia?drug-name=qsymia 20 82. Aetna.

229. Management of Suspected Opioid Overdose with Naloxone Guidelines by Emergency Medical Services Personnel | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/emt-naloxon/research-protocol
     November 30, 2016 - Interventions Drug, Dose and Route of Administration Included Drug Dose and Route of Administration … Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014. … Food and Drug Administration; 2014. … Food and Drug Administration; 2015. … drug overdose/ or opioid-related disorders/ Naloxone/ or naloxone.mp.

230. PHARMACO-EPIDEMIOLOGIC METHODS FOR A STUDY OF (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-mortality-elderly_research.pdf
     March 01, 2009 - and more likely to exclude those who discontinued the drug due to drug intolerance, or treatment failure … http://www.fda.gov/cder/drug/advisory/antipsychotics.htm http://www.fda.gov/cder/drug/advisory/antipsychotics.htm … Drug Saf 2007;30(1):47-57. 35. Wehmeier PM, Heiser P, Remschmidt H. … Adverse Drug React Toxicol Rev 2002;21(4):189-203. 38. Fox CS, Evans JC, Larson MG, et al. … Antipsychotic drug use and mortality in older adults with dementia.

231. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
     January 01, 2012 - A drug for psychotic major depression, for which the U.S. … dosages or different drug regimens. … administration and is known to be a street drug of abuse. … Research suggests new drug targets for depression. … Washington (DC): Drug Enforcement Administration, U.S.

232. S89 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s89.pdf
     October 01, 2007 - We are currently assessing the use of maxSPRT in drug safety monitoring.18 Drug safety studies entail … Other complications of drug safety studies include use of a drug for multiple indications, off-label … drug use, and potential differences between early and late adopters. … A maximized sequential probability ratio test for vaccine and drug safety surveillance. … Prompt, active, population-based identification of adverse drug reaction signals.

233. Ventricular Arrhythmias and Cerebrovascular Events in the Elderly Using Conventional and Atypical Antipsychotic Medications | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/antipsychotic-medicine-cardiovascular-elderly/research
     March 18, 2009 - Introduction The US Food and Drug Administration (FDA) issued an Advisory in 2005 that atypical antipsychotic … Reasons for using both drug groups (e.g., dementia, delirium) may themselves be risk factors for these … just new users to guard against selection bias among prevalent users from early symptom emergence, drug … Food and Drug Administration. … Available at: www.fda.gov/cder/drug/advisory/antipsychotics.htm . Accessed April 15, 2005. 2.

234. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_research-protocol.pdf
     March 09, 2010 - Furthermore, there are a large number of DMARDs that cannot simply be grouped by drug class. … Failure with a drug in one particular class does not necessarily predict failure with another drug in … available for much longer then the other DMARDs, so there is greater clinical experience with the drug … and the drug is relatively inexpensive. … Generic Name US Trade Name Drug Type Approved by the US Food and Drug Administration- for JIA

235. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/14_substanceabuse_potential_high_impact_june_2012.pdf
     January 01, 2012 - Food and Drug Administration (FDA) in October 2011 about preparing its new drug application, and the … company announced that FDA supported submission of a new drug application via the 505(b)(2) pathway … Public Health Service, guidelines for smoking cessation recommend drug therapy (e.g., bupropion and … National Institute on Drug Abuse (NIDA). Prescription drugs: abuse and addiction. [internet]. … Food and Drug Administration. [internet].

236. Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (… (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
     January 01, 2010 - United States Food and Drug Administration. FDA Statement on coronary drug-eluting stents. … United States Food and Drug Administration. … Update to FDA statement on coronary drug-eluting stents. … Effectiveness and Safety of Drug- Eluting Stents in Ontario. … : An Observational Study of Drug-Eluting Versus Bare-Metal Stents.

237. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - This drug is injected. … FDA approves Qsymia, a weight-loss drug. [internet]. … Food and Drug Administration (FDA); 2014 Jun 17. 78 p. … Food and Drug Administration (FDA); 2014 Jun 17. 89 p. … Food and Drug Administration.

238. Enzyme-Replacement Therapies for Lysosomal Storage Diseases | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/lysosomal-storage-diseases-therapies/technical-brief
     January 02, 2013 - Food and Drug Administration (FDA)-approved ERT for the treatment of six LSDs. … Technical Brief is to report what outcomes (benefits and harms) have been studied for a technology, drug … effectiveness review or systematic review that draws conclusions as to the clinical benefits and harms of a drug

239. Treatments for Fibromyalgia in Adult Subgroups | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/fibromyalgia/research
     January 26, 2015 - of patient-level RCT data, and 4 observational studies that met inclusion criteria; 59 percent were drug … Adults with fibromyalgia and major depressive disorder (MDD) were studied most often; drug studies also … Most drug trials examined duloxetine effects on pain and global improvement; trial duration was typically

240. PHARMACO-EPIDEMIOLOGIC METHODS FOR A STUDY OF (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-cardiovascular-elderly_research.pdf
     February 01, 2009 - Reasons for using both drug groups (e.g., dementia, delirium) may themselves be risk factors for these … just new users to guard against selection bias among prevalent users from early symptom emergence, drug … Food and Drug Administration. … Available at: www.fda.gov/cder/drug/advisory/antipsycho tics.htm. Accessed April 15, 2005. 2. … http://www.fda.gov/cder/drug/advisory/antipsychotics.htm http://www.fda.gov/cder/drug/advisory/antipsychotics.htm